I am a clinical health psychologist and behavioral scientist with expertise in addressing the psychological aspects of cancer risk, diagnosis, and treatment. As the psychology liaison to the Melanoma Disease Management Team, I specialize in the treatment of patients with melanoma, individuals who are at risk for developing melanoma, and their families.
Through the health behavior change and cancer risk reduction laboratory at Memorial Sloan Kettering’s Behavioral Sciences Service, I focus on cancer risk and health decision making. I am particularly involved in two areas: the science of risk perception, and cancer genomics and behavior. I work to optimize the translation of novel basic science, genomic, and epidemiological findings in cancer to health decision making among individuals across diverse populations and settings.
This work involves understanding cancer risk perceptions in the adoption of cancer prevention strategies, and psychological and behavioral approaches to melanoma prevention, control, and therapeutics. Psychological aspects of cancer genomics also play a role. I am funded by the National Institutes of Health to address these issues.
I also serve as a member of MSK’s Institutional Review Board, which meets regularly to review our hospital’s ongoing and proposed clinical research trials. I am a member of the Advisory Board within the Clinical Cancer Genetics Board for the National Cancer Institute’s Physician Data Query comprehensive database, and the Society of Behavioral Medicine’s Health Decision Making Special Interest Group.
- Clinical Expertise: Counseling and psychotherapy for cancer patients and family members; Behavioral Medicine; Psycho-Oncology; Health Psychology
- Languages Spoken: English
- Education: PhD, Derner Institute, Adelphi University
- Residencies: New York University Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more